Future Oncology · 2020 · 13 citations · 27 references
MedicineOncologyRadiation OncologyClinical Radiation OncologySurvival AnalysisThoracic OncologyCancer Survival AnalysisLung CancerRadiation TherapySurvival OutcomesCox RegressionDisease-free Survival AssessmentKaplan-meier Survival EstimatesLung Cancer StagingNeutrophil-to-lymphocyte RatioNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentOncologic Outcomes Assessment
Aim: To investigate the predictive potential of post-treatment neutrophil-to-lymphocyte ratio (NLR) and changes in this ratio (ΔNLR) for stage III non-small-cell lung cancer (NSCLC) patients who received conventionally fractionated radiotherapy (CFRT). Patients & methods: The data of 168 NSCLC patients treated at the Shandong Cancer Hospital were analyzed retrospectively. The relationship between progression-free survival (PFS), overall survival (OS) and post-treatment NLR and ΔNLR were analyzed using both Kaplan–Meier and Cox regression methods. Results: Kaplan–Meier survival analyses showed that post-treatment NLR and ΔNLR were associated with PFS (p < 0.001) and OS (p < 0.001) after CFRT. Multivariate analyses revealed that ΔNLR was an independent predictor of PFS (p = 0.001) and OS (p = 0.018). Post-treatment NLR can only be used as an independent predictor of PFS (p = 0.040). Conclusion: Our results demonstrated the prognostic value of the ΔNLR in predicting PFS and OS in stage III NSCLC patients undergoing CFRT. However, post-treatment NLR has predictive value only for PFS.
27
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2019 · 21K citations · Full text
Susannah Yovino, Lawrence Kleinberg, Stuart A. Grossman et al. · Cancer Investigation · 2013 · 408 citations · Full text